日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

一项 I 期临床试验,研究肝动脉内递送 TG6002 与口服 5-氟胞胞嘧啶联合治疗以肝脏转移为主的结直肠癌患者的疗效

West Emma J, Sadoun Alain, Bendjama Kaidre, Erbs Philippe, Smolenschi Cristina, Cassier Philippe A, de Baere Thierry, Sainte-Croix Sophie, Brandely Maud, Melcher Alan A, Ismail Fay, Scott Karen J, Bennett Angela, Banks Emma, Gasior Ewa, Kent Sarah, Kurzawa Marta, Hammond Christopher, Patel Jai V, Collinson Fiona J, Twelves Chris, Anthoney D Alan, Swinson Dan, Samson Adel

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

治疗性疫苗TG1050在慢性乙型肝炎患者中的安全性和免疫原性:一项1b期安慰剂对照试验

Zoulim, Fabien; Fournier, Claire; Habersetzer, François; Sprinzl, Martin; Pol, Stanislas; Coffin, Carla S; Leroy, Vincent; Ma, Mang; Wedemeyer, Heiner; Lohse, Ansgar W; Thimme, Robert; Lugardon, Karine; Martin, Perrine; Bastien, Bérangère; Sansas, Benoit; Adda, Nathalie; Halluard, Celine; Bendjama, Kaïdre; Brandely, Maud; Inchauspé, Geneviève